9 completed. 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 9 |
Follow AmBisome: new trials by email Literature Review of AmBisome trials Research Report on AmBisome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. Liposomal Amphotericin B, Miltefosine - Visceral Leishmaniasis | Phase 3 | Completed | Drugs for Neglected Diseases | 59 | 2014-07-01 | 2019-04-08 |
| Liposomal Amphotericin in Disseminated Leishmaniasis Liposomal Amphotericin B - Disseminated Leishmaniasis | Phase 3 | Completed | Hospital Universitário Professor Edgard Santos | 20 | 2011-04-01 | 2014-01-01 |
| Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia Liposomal amphotericin B, Placebo - Invasive Fungal Disease | Phase 3 | Completed | Gilead Sciences | 355 | 2011-04-01 | 2015-05-07 |
| Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh Liposomal amphotericin B, liposomal amphotericin B + miltefosine, liposomal amphotericin B + paromomycin - Visceral Leishmaniasis | Phase 3 | Completed | Drugs for Neglected Diseases | 602 | 2010-05-01 | 2016-01-21 |
| Liver Transplant European Study Into the Prevention of Fungal Infection micafungin, fluconazole, liposomal amphotericin B - Liver Transplantation, Mycoses | Phase 3 | Completed | Astellas Pharma Inc | 350 | 2009-12-15 | 2024-11-18 |
| To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar Amphotericin B Lipid emulsion, Liposomal Amphotericin B - Leishmaniasis, Visceral | Phase 3 | Completed | Bharat Serums and Vaccines Limited | 500 | 2009-07-01 | 2011-06-02 |
| Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis Liposomal Amphotericin B, amphotericin B deoxycholate - Visceral Leishmaniasis | Phase 3 | Completed | Banaras Hindu University | 400 | 2008-02-01 | 2009-04-03 |
| Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment AmBisome - Invasive Aspergillosis, Other Fungal Infections | Phase 3 | Completed | Gilead Sciences | 800 | 2003-04-01 | 2005-11-18 |
| Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia Micafungin, Liposomal Amphotericin B - Candidiasis | Phase 3 | Completed | Astellas Pharma Inc | 637 | 2003-01-01 | 2014-09-18 |
Leishmaniasis, Visceral (4) · Invasive Fungal Infections (2) · Candidemia (1) · Candidiasis (1) · Mycoses (1)
Astellas Pharma Inc (2) · Drugs for Neglected Diseases (2) · Gilead Sciences (2) · Banaras Hindu University (1) · Bharat Serums and Vaccines Limited (1) · Hospital Universitário Professor Edgard Santos (1)
India (2) · United Kingdom (2) · Austria (1) · Bangladesh (1) · Belgium (1) · Brazil (1) · Canada (1) · Ethiopia (1) · France (1) · Germany (1) · Hungary (1) · Ireland (1) · Italy (1) · Portugal (1) · Romania (1)
Dr. Gautam Daftary, MBBS (1) · Ermias Diro, Dr. MD (1) · Mike Hawkins, MD (1) · Paulo RL Machado, MD PhD (1) · Ridwanur Rahman, MD (1) · Shyam Sundar, MD (1)
PMID 19804626, PMID 20147716, PMID 21147825, PMID 25233346, PMID 25520332, PMID 26048961, PMID 28558062, PMID 30653490, PMID 30789910
2008 (1)